中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
金属研究所 [4]
上海药物研究所 [1]
昆明植物研究所 [1]
自动化研究所 [1]
采集方式
OAI收割 [7]
内容类型
期刊论文 [7]
发表日期
2021 [1]
2020 [1]
2018 [1]
2017 [4]
学科主题
筛选
浏览/检索结果:
共7条,第1-7条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
Musarin, a novel protein with tyrosine kinase inhibitory activity from Trametes versicolor, accepted inhibits colorectal cancer stem cell growth
期刊论文
OAI收割
BIOMEDICINE & PHARMACOTHERAPY, 2021, 卷号: 144, 页码: 112339
作者:
He,YingYing
;
Liu,Shubai
;
Newburg,David S.
  |  
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2022/04/02
Trametes versicolor
Cancer stem cell
Tyrosine kinase inhibitor
EGFR
Colorectal cancer
FACTOR RECEPTOR
POLYSACCHAROPEPTIDE
RESISTANCE
TARGET
EGFR
TOOL
PSP
DNA
CT-Based Radiomic Signature as a Prognostic Factor in Stage IV ALK-Positive Non-small-cell Lung Cancer Treated With TKI Crizotinib: A Proof-of-Concept Study
期刊论文
OAI收割
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10, 页码: 9
作者:
Li, Hailin
;
Zhang, Rui
;
Wang, Siwen
;
Fang, Mengjie
;
Zhu, Yongbei
  |  
收藏
  |  
浏览/下载:51/0
  |  
提交时间:2020/04/07
computed tomography
radiomics
non-small-cell lung cancer
tyrosine kinase inhibitor resistance
anaplastic lymphoma kinase
Design, synthesis and pharmacological evaluation of ALK and Hsp90 dual inhibitors bearing resorcinol and 2,4-diaminopyrimidine motifs
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 152, 页码: 76-86
作者:
Geng, Kaijun
;
Liu, Hongchun
;
Song, Zilan
;
Zhang, Chi
;
Zhang, Minmin
  |  
收藏
  |  
浏览/下载:147/0
  |  
提交时间:2019/01/08
Heat shock protein 90 (Hsp90)
Tyrosine kinase ALK
Dual inhibitor
Drug resistance
Antiproliferative activity
Identification of hydrazone moiety-bearing aminopyrimidines as potent antitumor agents with selective inhibition of gefitinib-resistant H1975 cancer cells
期刊论文
OAI收割
CHINESE CHEMICAL LETTERS, 2017, 卷号: 28, 期号: 5, 页码: 991-994
作者:
Qin MingZe
;
Wang Lei
;
Yan Shuang
;
Ma JunJie
;
Tian Ye
  |  
收藏
  |  
浏览/下载:46/0
  |  
提交时间:2021/02/02
TYROSINE KINASE INHIBITOR
LUNG-CANCER
RECEPTOR
T790M
MUTANT
MUTATION
Aminopyrimidines
EGFR T790M/L858R
Selectivity
Anti-resistance
Antiproliferative activity
Identification of hydrazone moiety-bearing aminopyrimidines as potent antitumor agents with selective inhibition of gefitinib-resistant H1975 cancer cells
期刊论文
OAI收割
CHINESE CHEMICAL LETTERS, 2017, 卷号: 28, 期号: 5, 页码: 991-994
作者:
Qin MingZe
;
Wang Lei
;
Yan Shuang
;
Ma JunJie
;
Tian Ye
  |  
收藏
  |  
浏览/下载:46/0
  |  
提交时间:2021/02/02
TYROSINE KINASE INHIBITOR
LUNG-CANCER
RECEPTOR
T790M
MUTANT
MUTATION
Aminopyrimidines
EGFR T790M/L858R
Selectivity
Anti-resistance
Antiproliferative activity
Design, Synthesis and Biological Activities of N-(Furan-2-ylmethyl)-1H-indole-3-carboxamide Derivatives as Epidemal Growth Factor Receptor Inhibitors and Anticancer Agents
期刊论文
OAI收割
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2017, 卷号: 33, 期号: 3, 页码: 365-372
作者:
Zhang Lan
;
Deng Xinshan
;
Wu Jiaofeng
;
Meng Guangpeng
;
Liu Congchong
  |  
收藏
  |  
浏览/下载:51/0
  |  
提交时间:2021/02/02
MOLECULAR TARGETED DRUGS
TYROSINE KINASE
CANCER-CELLS
EGFR
RESISTANCE
POTENT
DISCOVERY
NSCLC
Anticancer activity
Epidemal growth factor receptor(EGFR) inhibitor
N-( Furan-2-ylmethyl)-1H-indole3-carboxamide derivative
Design, Synthesis and Biological Activities of N-(Furan-2-ylmethyl)-1H-indole-3-carboxamide Derivatives as Epidemal Growth Factor Receptor Inhibitors and Anticancer Agents
期刊论文
OAI收割
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2017, 卷号: 33, 期号: 3, 页码: 365-372
作者:
Zhang Lan
;
Deng Xinshan
;
Wu Jiaofeng
;
Meng Guangpeng
;
Liu Congchong
  |  
收藏
  |  
浏览/下载:49/0
  |  
提交时间:2021/02/02
MOLECULAR TARGETED DRUGS
TYROSINE KINASE
CANCER-CELLS
EGFR
RESISTANCE
POTENT
DISCOVERY
NSCLC
Anticancer activity
Epidemal growth factor receptor(EGFR) inhibitor
N-( Furan-2-ylmethyl)-1H-indole3-carboxamide derivative